14:49:11 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



T:MSCL - SATELLOS BIOSCIENCE INC. - https://satellos.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MSCL - T  8.00.43·0.440.50.44+0.012.359.125320.43  0.45  0.430.80  0.2914:19:23Apr 0815 min RT 2¢
TSX - T8.00.43·0.440.50.44+0.012.342.518130.43  0.45  0.430.80  0.2914:19:2315 min
NEO ATS - U 0.432.5140.43  0.43  0.4312:33:2315 min
Pure - P 0.44+0.012.33.0130.45  0.45  0.4414:19:2315 min
CX2 - H 0.45+0.024.710.5480.43  0.45  0.4313:03:3815 min
CXD - D 0.430.23    May 0315 min
TriAct - M 0.430.401    15 min

Recent Trades - Last 10 of 32
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:19:23P0.440.015001 Anonymous1 AnonymousK
14:19:23T0.440.015001 Anonymous1 AnonymousK
13:03:38H0.450.025002 RBC80 National BankK
13:03:38T0.450.021,50079 CIBC80 National BankK
13:03:38T0.450.0250079 CIBC79 CIBCK
12:50:52D0.470.049880 National Bank14 Virtu ITGE
12:44:14P0.450.022,00079 CIBC5 CitadelK
12:44:14P0.450.0250079 CIBC1 AnonymousK
12:44:14T0.450.0250079 CIBC2 RBCK
12:33:23T0.43 4,50022 Fidelity2 RBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-27 16:42C:MSCL0.48SEDAR MD & ASEDAR MD & A
2024-03-27 15:50C:MSCL0.46SEDAR MD & ASEDAR MD & A
2024-03-27 15:44C:MSCL0.46SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-27 15:44C:MSCL0.46SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-27 11:14C:MSCL0.48News ReleaseSatellos Bioscience's Dec. 31 cash at $39.6-million
2024-02-14 11:10C:MSCL0.55News ReleaseSatellos Bioscience to begin trading on TSX Feb. 15
2024-02-13 19:56C:MSCL0.55Shares Delisted from TSX-VSatellos Bioscience to be delisted from TSX-V
2024-02-13 15:01C:MSCL0.55New ListingSatellos Bioscience to trade on TSX Feb. 15
2024-02-13 11:19C:MSCL0.53News ReleaseSatellos Bioscience releases SAT-3247 preliminary data
2024-01-26 11:38C:MSCLSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-01-23 10:08C:MSCL0.55News ReleaseSatellos names Dubow chief medical adviser
2024-01-16 11:45C:MSCL0.45News ReleaseSatellos Bioscience receives cond. OK for TSX listing
2023-11-22 14:30C:MSCL0.50SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-22 14:28C:MSCL0.50SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-22 10:41C:MSCL0.475News ReleaseSatellos Bioscience's Sept. 30 cash at $44.3-million
2023-11-14 13:38C:MSCL0.35News ReleaseSatellos sets AAK1 as drug target to treat Duchenne
2023-09-07 17:15C:MSCL0.495News ReleaseSatellos hires ICP for market making services
2023-09-05 14:28C:MSCL0.415News ReleaseSatellos Bioscience appoints Williams as CFO
2023-08-29 12:50C:MSCL0.45News ReleaseSatellos Bioscience spends $873,012 on R&D in Q2
2023-08-28 07:02C:MSCL0.45SEDAR Interim Financial StatementsSEDAR Interim Financial Statements